Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Non-cash Items: 2018-2024

Historic Non-cash Items for Crinetics Pharmaceuticals (CRNX) over the last 7 years, with Dec 2024 value amounting to $6.5 million.

  • Crinetics Pharmaceuticals' Non-cash Items fell 97.42% to $7.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $7.5 million, marking a year-over-year decrease of 97.42%. This contributed to the annual value of $6.5 million for FY2024, which is 23.27% up from last year.
  • Latest data reveals that Crinetics Pharmaceuticals reported Non-cash Items of $6.5 million as of FY2024, which was up 23.27% from $5.3 million recorded in FY2023.
  • In the past 5 years, Crinetics Pharmaceuticals' Non-cash Items ranged from a high of $4.1 billion in FY2022 and a low of $2.0 million during FY2020.
  • In the last 3 years, Crinetics Pharmaceuticals' Non-cash Items had a median value of $6.5 million in 2024 and averaged $1.4 billion.
  • Per our database at Business Quant, Crinetics Pharmaceuticals' Non-cash Items spiked by 4,995.56% in 2022 and then plummeted by 99.87% in 2023.
  • Crinetics Pharmaceuticals' Non-cash Items (Yearly) stood at $2.0 million in 2020, then skyrocketed by 4,033.33% to $80.9 million in 2021, then soared by 4,995.56% to $4.1 billion in 2022, then crashed by 99.87% to $5.3 million in 2023, then grew by 23.27% to $6.5 million in 2024.